Hanmi Pharm. Co.

128940.KO

159.48 USD

-2.64

-1.63%

Overview

Last close

159.48 usd

Market cap

2.02B usd

52 week high

279.43 usd

52 week low

159.48 usd

Target price

245.11 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.9841

Price/Book Value

2.735

Enterprise Value

2.23B usd

EV/Revenue

2.187

EV/EBITDA

11.1642

Key financials

Revenue TTM

1.02B usd

Gross Profit TTM

555.86M usd

EBITDA TTM

210.80M usd

Earnings per Share

N/A usd

Dividend

0.85 usd

Total assets

1.37B usd

Net debt

200.43M usd

About

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company has a research collaboration with MEDIC Life Sciences Inc. to identify cancer biomarkers. The company was founded in 1973 and is based in Hwaseong-si, South Korea.